Neoadjuvant Nab-Paclitaxel and S-1 in Resectable Pancreatic Cancer
Clinical trial NCT04808687 · UNKNOWN
Trial details
- NCT number
- NCT04808687
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-01
- Primary completion
- 2023-02-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.